Skip to content

Effectiveness of the Mind-Regulating and Depression-Relieving Therapy in Enhancing the Treatment Outcomes of Colorectal Cancer

Effectiveness of the Mind-Regulating and Depression-Relieving Therapy in Enhancing the Treatment Outcomes of Colorectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000415
Enrollment
Unknown
Registered
2026-02-25
Start date
2022-09-14
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Intervention group:Basic treatment combined with traditional Chinese medicine for regulating spirit and relieving depression group
control group:Basic treatment combined with traditional Chinese medicine placebo group

Sponsors

Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Colorectal cancer patients, pathologically confirmed as adenocarcinoma, mucinous adenocarcinoma, and signet ring cell carcinoma; 2) Patients with an expected survival period of = 6 months; 3) Individuals with a PHQ-9 Depression Scale score = 5 or a GAD-7 Anxiety Scale score>0; 4) At least one measurable lesion displayed by imaging examinations (PET-CT, CT, MRI); 5) Age = 18 years old and = 80 years old; 6) The patient has good compliance and is able to understand the situation of this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Merge primary tumors from other parts; 2) Individuals with significant impairment of heart, liver, kidney, or hematopoietic function; 3) Those who have not completed 4 cycles of chemotherapy or traditional Chinese medicine use; 4) Merge active tuberculosis or infected individuals; 5) Poor compliance and inability to complete the study; 6) Participated in other clinical trials within the past month; 7) Pregnant or lactating women.

Design outcomes

Secondary

MeasureTime frame
Overall survival;Quality of life;Traditional Chinese Medicine Syndrome Indicators;Immune function;The degree of emotional disorders in patients;Gut microbiota;

Primary

MeasureTime frame
Progression-free survival;

Countries

China

Contacts

Public ContactYan Wang

Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital Cancer Research Institute

2020331697@qq.com17717074405

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026